Top

Published in:

01-12-2005

Evaluation of Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy

Authors: Robert C. G. Martin, MD, Samuel R. Wellhausen, PhD, Dave A. Moehle, BS, Alvin W. Martin, MD, Kelly M. McMasters, MD, PhD

Published in: Annals of Surgical Oncology | Issue 12/2005

Abstract

Background

Hepatectomy and pancreatectomy are often associated with significant intraoperative blood loss leading to postoperative anemia, which has been demonstrated to lead to increased perioperative morbidity, a prolonged hospital stay, and decreased overall survival. Cancer has remained an absolute contraindication to autotransfusion because of the unproven concern about reinfusion of malignant cells. Thus, the aim of this study was to test for the presence of malignant cells in autotransfused filtered blood in patients undergoing major pancreatic and liver resection.

Methods

A prospective study of 20 consecutive patients evaluated the presence of malignant cells from autotransfusion filtered blood after resection by flow cytometric and immunohistochemical methods.

Results

Ten patients underwent major hepatectomy for metastatic colorectal cancer, with a median blood loss of 500 mL (range, 200–700 mL). Three patients received a total of six units of packed red blood cells. Ten patients underwent pancreaticoduodenectomy for adenocarcinoma with a median blood loss of 400 mL (range, 200–1300 mL). Five patients received a total of nine units of packed red blood cells. Flow cytometry did not demonstrate the presence of any cytokeratin-positive carcinoma cells in filtered blood.

Conclusions

Intraoperative autotransfusion for major hepatectomy in metastatic colorectal cancer and pancreatectomy for adenocarcinoma is safe and should begin to be evaluated in a phase II study for efficacy.

Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236:397–407CrossRefPubMed

Martin RC, Jarnagin WR, Fong Y, Biernacki P, Blumgart LH, DeMatteo RP. The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: is there a standard for transfusion? J Am Coll Surg 2003;196:402–9CrossRefPubMed

Sarr MG. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg 2003;196:556–64PubMed

Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 1999;229:613–22CrossRefPubMed

Martin RC, Jaques DP, Brennan MF, Karpeh M. Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection? J Am Coll Surg 2002;194:568–77CrossRefPubMed

Griffin SM, Shaw IH, Dresner SM. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management. J Am Coll Surg 2002;194:285–97CrossRefPubMed

Hollenbeck ST, Grobmyer SR, Kent KC, Brennan MF. Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg 2003;197:575–9CrossRefPubMed

Kooby DA, Stockman J, Ben Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003;237:860–9PubMed

Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 1991;214:107–13PubMed

10.

Basu P. Fear flows as efforts to ease blood shortage continue in vein. Nat Med 2003;9:1336PubMed

11.

Popovsky MA, Devine PA, Taswell HF. Intraoperative autologous transfusion. Mayo Clin Proc 1985;60:125–34PubMed

12.

Klimberg I, Sirois R, Wajsman Z, Baker J. Intraoperative autotransfusion in urologic oncology. Arch Surg 1986;121:1326–9PubMed

13.

Hart OJ III, Klimberg IW, Wajsman Z, Baker J. Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surg Gynecol Obstet 1989;168:302–6PubMed

14.

Pisters LL, Wajsman Z. Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery. Urology 1992;40:211–5CrossRefPubMed

15.

Zulim RA, Rocco M, Goodnight JE Jr, Smith GJ, Krag DN, Schneider PD. Intraoperative autotransfusion in hepatic resection for malignancy. Is it safe? Arch Surg 1993;128:206–11PubMed

16.

Ereth MH, Oliver WC Jr, Santrach PJ. Perioperative interventions to decrease transfusion of allogeneic blood products. Mayo Clin Proc 1994;69:575–86PubMed

17.

Popovsky MA, Devine PA, Taswell HF. Intraoperative autologous transfusion. Mayo Clin Proc 1985;60:125–34PubMed

18.

Giordano GF. Management of Surgical Blood Loss. Washington DC: American Red Cross, 1993

19.

Haemonetics Corporation. Cell Saver®5+ Autologous Blood Recovery System—Operator’s Manual. Braintree, MA: Haemonetics Corporation, 2004.

20.

Martin AW, Braye A, Wellhausen SR, Periper SC. Detection of metastatic breast cancer cells in bone marrow: flow cytometry vs automated image analysis. Am J Clin Pathol 2000;114:629–59

21.

22.

Klein HG. Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 1999;91:861–5CrossRefPubMed

23.

Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236:397–407CrossRefPubMed

24.

Conlon KC, Labow D, Leung D, et al. Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg 2001;234:487–93CrossRefPubMed

25.

Conlon KC, Labow D, Leung D, et al. Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg 2001;234:487–93CrossRefPubMed

26.

Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. Lancet 2003;361:161–9CrossRefPubMed

27.

Narvios AB, Lichtiger B, Newman JL. Underreporting of minor transfusion reactions in cancer patients. Med Gen Med 2004;6:17

28.

Ereth MH, Oliver WC Jr, Santrach PJ. Perioperative interventions to decrease transfusion of allogeneic blood products. Mayo Clin Proc 1994;69:575–86PubMed

29.

Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990;30:583–90CrossRefPubMed

30.

Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion 1992;32:601–6CrossRefPubMed

31.

Chan AC, Blumgart LH, Wuest DL, Melendez JA, Fong Y. Use of preoperative autologous blood donation in liver resections for colorectal metastases. Am J Surg 1998;175:461–5CrossRefPubMed

32.

Hobisch-Hagen P, Schobersberger W, Falkensammer J, et al. No release of cardiac troponin I during major orthopedic surgery after acute normovolemic hemodilution. Acta Anaesthesiol Scand 1998;42:799–804PubMedCrossRef

33.

Kahraman S, Altunkaya H, Celebioglu B, Kanbak M, Pasaoglu I, Erdem K. The effect of acute normovolemic hemodilution on homologous blood requirements and total estimated red blood cell volume lost. Acta Anaesthesiol Scand 1997;41:614–7PubMed

34.

Nuttall GA, Erchul DT, Haight TJ, et al. A comparison of bleeding and transfusion in patients who undergo coronary artery bypass grafting via sternotomy with and without cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2003;17:447–51

35.

Shulman G, Grecula MJ, Hadjipavlou AG. Intraoperative autotransfusion in hip arthroplasty. Clin Orthop 2002;119–30

36.

Patra P, Chaillou P, Bizouarn P. Intraoperative autotransfusion for repair of unruptured aneurysms of the infrarenal abdominal aorta. A multicenter study of 203 patients. Association Universitaire de Recherche en Chirurgie (AURC). J Cardiovasc Surg (Torino) 2000;41:407–13

37.

Homann B, Zenner HP, Schauber J, Ackermann R. Tumor cells carried through autotransfusion. Are these cells still malignant? Acta Anaesthesiol Belg 1984;35(Suppl):51–9PubMed

38.

Miller GV, Ramsden CW, Primrose JN. Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer. Br J Surg 1991;78:713–5PubMed

39.

Edelman MJ, Potter P, Mahaffey KG, Frink R, Leidich RB. The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. Urology 1996;47:179–81CrossRefPubMed

Title: Evaluation of Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy
Authors: Robert C. G. Martin, MD
Samuel R. Wellhausen, PhD
Dave A. Moehle, BS
Alvin W. Martin, MD
Kelly M. McMasters, MD, PhD
Publication date: 01-12-2005
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 12/2005
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/ASO.2005.12.018

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Evaluation of Intraoperative Autotransfusion Filtration for Hepatectomy and Pancreatectomy

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2005

Timing of Critical Genetic Changes in Human Breast Disease

Herpes Simplex Virus Amplicon Delivery of a Hypoxia-Inducible Soluble Vascular Endothelial Growth Factor Receptor (sFlk-1) Inhibits Angiogenesis and Tumor Growth in Pancreatic Adenocarcinoma

Tumor Regression and Autoimmunity in CytotoxicT Lymphocyte–Associated Antigen 4 Blockade–Treated Patients

Evaluation of Residual Glandular Tissue After Skin-Sparing Mastectomies

Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

Is Radical Surgery Necessary for Early-Stage Ampullary Tumors?